Intrinsically Cancer-Mitochondria-Targeted Thermally Activated Delayed Fluorescence Nanoparticles for Two-Photon-Activated Fluorescence Imaging and Photodynamic Therapy

A recent breakthrough in the discovery of thermally activated delayed fluorescence (TADF) emitters characterized by small single-triplet energy offsets (ΔE ST) offers a wealth of new opportunities to exploit high-performance metal-free photosensitizers. In this report, two intrinsically cancer-mitoc...

Full description

Saved in:
Bibliographic Details
Published inACS applied materials & interfaces Vol. 11; no. 44; pp. 41051 - 41061
Main Authors Zhang, Jinfeng, Fang, Fang, Liu, Bin, Tan, Ji-Hua, Chen, Wen-Cheng, Zhu, Zelin, Yuan, Yi, Wan, Yingpeng, Cui, Xiao, Li, Shengliang, Tong, Qing-Xiao, Zhao, Junfang, Meng, Xiang-Min, Lee, Chun-Sing
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 06.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A recent breakthrough in the discovery of thermally activated delayed fluorescence (TADF) emitters characterized by small single-triplet energy offsets (ΔE ST) offers a wealth of new opportunities to exploit high-performance metal-free photosensitizers. In this report, two intrinsically cancer-mitochondria-targeted TADF emitters-based nanoparticles (TADF NPs) have been developed for two-photon-activated photodynamic therapy (PDT) and fluorescence imaging. The as-prepared TADF NPs integrate the merits of (1) high 1O2 quantum yield of 52%, (2) sufficient near-infrared light penetration depth due to two-photon activation, and (3) excellent structure-inherent mitochondria-targeting capabilities without extra chemical or physical modifications, inducing remarkable endogenous mitochondria-specific reactive oxygen species production and excellent cancer-cell-killing ability at an ultralow light irradiance. We believe that the development of such intrinsically multifunctional TADF NPs stemming from a single molecule will provide new insights into exploration of novel PDT agents with strong photosensitizing ability for various biomedical applications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1944-8244
1944-8252
DOI:10.1021/acsami.9b14552